Header image

Australia as a global leader in clinical trials

Tracks
Track 1
Thursday, May 8, 2025
12:30 PM - 1:15 PM

Details

This session will highlight why Australia is emerging as a global leader in clinical trials, exploring its competitive advantages, challenges, and the policies driving its success. With a robust healthcare system, well-established regulatory environment, and skilled workforce, Australia provides an ideal setting for high-quality clinical research. The country’s cost-effectiveness, fast patient recruitment, and adherence to international standards make it an attractive location for global pharmaceutical and Medtech companies. Real-life examples of companies choosing Australia for clinical trials, such as those in the pharmaceutical and medical device sectors, will be discussed, demonstrating the country’s ability to manage complex trials efficiently. The session will also cover the challenges faced by the clinical trial industry, including policy changes, patient safety concerns, and the need for ethical oversight. Attendees will gain valuable insights into how Australia’s strengths position it as a key player in global clinical research and innovation.


Speaker

Dr Deama Amr
Director Clinical Research and Medical Science ANZ
Medtronic

Panellist

Anne O'Neill
Director, Enterprise, International Partnerships and Clinical Trials
NSW Health and Medical Research

Chair

Deborah Bell
Executive Director, Business Development
Avania

Panellist

loading